BlackRock Science & Technology Opp R
100 Bellevue Parkway Wilmington, DE 19809
Phone: 800-441-7762
| Category: | Technology | | Fund Family: | BlackRock | | Net Assets: | 1.55M | | Year-to-Date Return: | 19.19% | | Yield: | % | | Morningstar Rating: | N/A | | Fund Inception Date: | 09-Sep-08 |
|
Thomas P. Callan
Lead Manager since
15-May-00 | | | Callan is managing director and senior portfolio manager with BlackRock, his employer since 1996. Previously, he was with the PNC Asset Management Group, which he joined in 1992. |
| Min Initial Investment: | $100 | | Min Initial Investment, IRA: | $100 | | Min Initial Investment, AIP: | $0 | | Min Subsequent Investment: | $50 | | Min Subsequent Investment, IRA: | $50 | | Min Subsequent Investment, AIP: | $0 |
|
| |
| The investment seeks long-term capital appreciation. The fund normally invests at least 80% of net assets in equity securities issued by science and technology companies in all market capitalization ranges. It invests up to 25% of net assets in stocks of issuers in emerging market countries. The fund invests primarily in equity securities of U.S. and non-U.S. companies in all capitalization ranges. It may invest in shares of companies through initial public offerings (IPOs) and in derivative instruments. |
| Last Dividend
| N/A | | Last Cap Gain
| N/A | | Annual Holdings Turnover
| 89.00% | | Average for Category:
| 192.30% |
|
| Expense | BGSRX | Category
Avg | | Total Expense Ratio: | 2.13%
| 1.78% | | Max 12b1 Fee: | 0.25%
| N/A | | Max Front End Sales Load: | 0.00%
| 5.38% | | Max Deferred Sales Load: | 0.00%
| 2.69% | | 3 Yr Expense Projection*: |
$739 | $726 | | 5 Yr Expense Projection*: |
$1,265 | $1,127 | | 10 Yr Expense Projection*: |
$2,706 | $2,232 |
|
|
0.10 (1.29%)
